Helsinki, Finland, April 5, 2016 -- Metso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the holding of mutual funds managed by BlackRock, Inc. of the total amount of shares and financial instruments entitling to shares of Metso Corporation.
On April 4, 2016, BlackRock, Inc.'s aggregate direct holding in Metso exceeded the 5 percent threshold. BlackRock, Inc.'s direct holding on April 4, 2016, amounted to 7,816,776 shares and corresponded to 5.19 percent of Metso's shares and votes.
On April 4, 2016, BlackRock, Inc.'s aggregate direct holding and holding through financial instruments in Metso Corporation amounted to 10,161,873 shares, which corresponds to 6.75 percent of the total amount of shares in Metso Corporation.
Metso is a world leading industrial company serving the mining, aggregates, recycling, oil, gas, pulp, paper and process industries. We help our customers improve their operational efficiency, reduce risks and increase profitability by using our unique knowledge, experienced people and innovative solutions to build new, sustainable ways of growing together.
Our products range from mining and aggregates processing equipment and systems to industrial valves and controls. Our customers are supported by a broad scope of services and a global network of over 80 service centers and about 6,400 services professionals. Metso has an uncompromising attitude towards safety.
Metso is listed on the NASDAQ OMX Helsinki, Finland, and had net sales of about EUR 2.9 billion in 2015. Metso employs over 12,000 persons in more than 50 countries. Expect results.
www.metso.com , www.twitter.com/metsogroup
Further information, please contact:
Juha Rouhiainen, VP, Investor Relations, Metso Corporation, tel +358 20 484 3253
Metso Corporation
Harri Nikunen
CFO
Juha Rouhiainen
VP, Investor Relations
Distribution:
NASDAQ OMX Helsinki Ltd
Media
www.metso.com
HUG#2000769


Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
FDA Approves Mitapivat for Anemia in Thalassemia Patients
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 



